MAXCYTE, INC. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$7M↓-16.0%
2025-09-30$7M↓-16.4%$-12M↓-7.4%-207.2%
2025-06-30$9M↓-18.4%$-12M↓-31.8%-167.2%
2025-03-31$10M↓-8.4%$-10M↓-7.7%-118.3%
2024-12-31$9M↓-44.5%
2024-09-30$8M↑+2.0%$-12M↓-2.7%-172.1%
2024-06-30$10M↑+15.3%$-9M↑+10.8%-114.8%
2024-03-31$11M↑+32.3%$-10M↑+12.5%-108.2%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$7M
↓-16.0% -$1M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 24 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+4.2pts
77.9%
Operating Margin↓-35.1pts
-207.2%
Net Margin↓-40.3pts
-181.8%

Go deeper